elf Beauty Inc
For the period ended Dec 31, 2024. Filed Feb 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Feb 7, 2025
ELF$118.51-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed consolidated statements of cash flows
(in thousands)
| Nine months ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net income | $83,836 | $113,136 |
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 30,899 | 20,445 |
| Non-cash lease expense | 7,010 | 3,802 |
| Stock-based compensation expense | 56,951 | 29,459 |
| Amortization of debt issuance costs and discount on debt | 413 | 290 |
| Deferred income taxes | (4,153) | (1,684) |
| Impairment of equity investment | — | 1,720 |
| Acquisition-related seller expenses | — | (10,549) |
| Other, net | 844 | 27 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (65,067) | (45,878) |
| Inventory | (23,652) | (106,898) |
| Prepaid expenses and other assets | (77,534) | (50,696) |
| Accounts payable and accrued expenses | (5,691) | 84,733 |
| Other liabilities | (6,116) | (3,768) |
| Net cash (used in) provided by operating activities | (2,260) | 34,139 |
| Cash flows from investing activities: | ||
| Acquisition, net of cash acquired | — | (274,973) |
| Purchase of property and equipment | (7,461) | (5,984) |
| Other, net | (278) | — |
| Net cash used in investing activities | (7,739) | (280,957) |
| Cash flows from financing activities: | ||
| Proceeds from revolving line of credit | — | 89,500 |
| Proceeds from long-term debt | — | 115,000 |
| Repayment of long-term debt | (8,062) | (5,188) |
| Debt issuance costs paid | — | (665) |
| Repurchase of common stock | (17,076) | — |
| Proceeds from exercise of stock options | 917 | 2,893 |
| Other, net | (57) | (489) |
| Net cash (used in) provided by financing activities | (24,278) | 201,051 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (61) | (56) |
| Net decrease in cash, cash equivalents and restricted cash | (34,338) | (45,823) |
| Cash, cash equivalents and restricted cash - beginning of period | 108,183 | 120,778 |
| Cash, cash equivalents and restricted cash - end of period | $73,845 | $74,955 |
The following table provides a reconciliation of cash, cash equivalents and restricted cash recorded in the condensed consolidated balance sheets to amounts reported in the condensed consolidated statements of cash flows (in thousands):
| Balance sheet classification | December 31, 2024 | March 31, 2024 | December 31, 2023 |
|---|---|---|---|
| Cash and cash equivalents | $73,845 | $108,183 | $72,705 |
| Restricted cash (included in Prepaid expenses and other current assets) | — | — | 2,250 |
| Total cash, cash equivalents and restricted cash | $73,845 | $108,183 | $74,955 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.